Delivery Order SPE2DR25D1017-SPE2DR26F9CAJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,266.70 to AmerisourceBergen Drug Corp for the supply of Tavalisse 100 mg tablets (60-count) under a firm fixed-price contract type. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,797.57 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count units) on November 24, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,266.70 to AmerisourceBergen Drug Corp for the supply of Tavalisse 100 mg tablets (60 count) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of October 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance of the work taking place at its corporate office location...
- The Defense Logistics Agency awarded a Delivery Order contract valued at $9,797.57 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count units). This non-competitive, firm fixed-price delivery order was issued on November 5, 2025, with an ultimate completion date of November 28, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count) on August 15, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 150 mg, a pharmaceutical product delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Tavalisse 100 mg tablets (60-count units). This is a non-set-aside contract with a completion date of July 31, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CAJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,797.57 to AmerisourceBergen Drug Corp for Tavalisse 150 mg tablets (60-count supply) with a completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate operations as a major healthcare solutions provider serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor for this expansive contract vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including products for the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its established capability to meet rigorous federal procurement requirements for specialized pharmaceutical products and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 12/22/25 |